Predilife S.A. (EPA:ALPRE)

France · Delayed Price · Currency is EUR

3.100

+0.050 (1.64%)

Apr 24, 2026, 2:57 PM CET

Revenue by Segment

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceuticals	493.20K	317.79K	288.60K	142.08K	51.57K
Pharmaceuticals Growth	55.20%	10.11%	103.12%	175.51%	125.48%
Total	493.20K	317.79K	288.60K	142.08K	51.57K
Total Growth	55.20%	10.11%	103.12%	175.51%	125.48%

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
France	492.27K	314.85K	202.15K	112.09K	-
France Growth	56.35%	55.75%	80.35%	-	-
Italy	930.00	2.95K	80.13K	-	-
Italy Growth	-68.42%	-96.32%	-	-	-
Belgium	-	-	4.20K	-	-
Greece	-	-	2.13K	-	-
Export	-	-	-	30.00K	-
Total	493.20K	317.79K	288.60K	142.08K	-
Total Growth	55.20%	10.11%	103.12%	-	-

Source: S&P Global Market Intelligence.